Posterior Vitreous Detachment and Its Role in the Evolution of Dry to Wet Age Related Macular Degeneration

References

• Spaide RF, Armstrong D, Browne R. Choroidal neovascularization in age related macular degeneration - what is the cause? Retina. 2003;23:595–614. doi:10.1097/00006982-200310000-00001
   PubMed Web of Science ®Google Scholar
• Ondes F, Yilmaz G, Acar MA, Unlü N, Kocaoğlan H, Arsan AK. Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol. 2000;91–93. doi:10.1016/S0021-5155(99)00174-4
   PubMed Web of Science ®Google Scholar
• Weber-Krause B, Eckardt C. Incidence of posterior vitreous detachment in the elderly. Ophthalmologe. 1997;94:619–623. doi:10.1007/s003470050170
   PubMed Web of Science ®Google Scholar
• Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S. Posterior macular adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol. 2007;135:351–355. doi:10.1016/s0002-9394(02)01944-x
   Google Scholar
• Johnson MW. Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc. 2005;103:537–567.
   PubMedGoogle Scholar
• Kim YC, Harasawa M, Villanueva GS, et al. Enhanced high-density line spectral-domain optical coherence tomography imaging of the vitreoretinal interface: description of selected cases. Semin Ophthalmol. 2016;31:559–566. doi:10.3109/08820538.2015.1009560
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Waldstein SM, Klimscha S, et al. Prediction of individual disease conversion in early AMD using artificial intelligence. Invest Ophthalmol Vis Sci. 2018;59(8):3199–3208.
   PubMed Web of Science ®Google Scholar
• Clemons TE, Milton RC, Klein R, et al; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19. Ophthalmology. 2005;112:533–539.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Augood C, Bentham GC, et al. Cigarette smoking and age-related macular degeneration in the EUREYE study. Ophthalmology. 2007;114(6):1157–1163. doi:10.1016/j.ophtha.2006.09.022
   PubMed Web of Science ®Google Scholar
• Francis PJ, George S, Schultz Francis DW, et al. The LOC387715 gene, smoking, body mass index, environmental association with advanced age-related macular degeneration. Hum Hered. 2007;63:212–218.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Risk factors associated with age- related macular degeneration. A case-control study in the age-related eye disease study: age- Related Eye Disease Study (AREDS) Report No. 3. Ophthalmology. 2000;107(12):2224–2232.
   PubMed Web of Science ®Google Scholar
• Edwards A, Ritter R, Kenneth JA, Manning A, Panhuysen C, Farrer L. Complement factor H polymorphism and age- related macular degeneration. Science. 2005;308:421–424. doi:10.1126/science.1110189
   PubMed Web of Science ®Google Scholar
• Scott WK, Schmidt S, Hauser M, et al. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. Ophthalmology. 2007;114:1151–1156. doi:10.1016/j.ophtha.2006.08.054
   PubMed Web of Science ®Google Scholar
• Souied EH, Benlian P, Amouyel P, et al. The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 1998;125(3):353–359. doi:10.1016/S0002-9394(99)80146-9
   PubMed Web of Science ®Google Scholar
• Churchill AJ, Carter JG, Lovell H, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet. 2006;15:2955–2961. doi:10.1093/hmg/ddl238
   PubMed Web of Science ®Google Scholar
• Schulze S, Neugebauer A, KrollSchulze P. Appearance of age-related macular degeneration in vitrectomized and nonvitrectomized eyes: an intraindividual case study. Acta Ophthalmol. 2012;90(3):244–247. doi:10.1111/j.1755-3768.2010.01929.x
   PubMed Web of Science ®Google Scholar
• Nomura Y, Ueta T, Iriyama A, et al. Vitreomacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmology. 2011;118(5):853–859. doi:10.1016/j.ophtha.2010.09.001
   PubMed Web of Science ®Google Scholar
• Jackson T, Nicod E, Angelis A, et al. Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and meta-analysis. Retina. 2013;33(6):1099–1108. doi:10.1097/IAE.0b013e31828991d6
   PubMed Web of Science ®Google Scholar
• Anderson DH, Mullins R, Hageman G, et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134(3):411–431. doi:10.1016/S0002-9394(02)01624-0
   PubMed Web of Science ®Google Scholar
• Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51:137–152. doi:10.1016/j.survophthal.2005.12.001
   PubMed Web of Science ®Google Scholar
• Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122(4):598–614. doi:10.1001/archopht.122.4.598
   PubMed Web of Science ®Google Scholar
• Stefánsson E, Geirsdóttir A, Sigurdsson H. Metabolic physiology in age related macular degeneration. Prog Retin Eye Res. 2011;30(1):72–80. doi:10.1016/j.preteyeres.2010.09.003
   PubMed Web of Science ®Google Scholar
• Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005;25(2):111–118. doi:10.1097/00006982-200502000-00001
   PubMed Web of Science ®Google Scholar
• Ma L, Brelen M, Tsujikawa M, et al. Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations. Invest Ophthalmol Vis Sci. 2017;58(2):1076–1083. doi:10.1167/iovs.16-20575
   PubMed Web of Science ®Google Scholar
• Danny SN, Yip YW, Bakthavatsalam M, et al. Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation. Sci Rep. 2017;7(1):45081
   PubMedGoogle Scholar
• Ilim O, Akkin C, Oztas Z, et al. The role of posterior vitreous detachment and vitreomacular adhesion in patients with age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2017;48(3):223–229. PMID: 28297034. doi:10.3928/23258160-20170301-05
   PubMed Web of Science ®Google Scholar
• Waldstein S, Wright J, Warburton J, et al. Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD. Ophthalmology. 2016;123(1):60–69. doi:10.1016/j.ophtha.2015.09.013
   PubMed Web of Science ®Google Scholar
• Awasthi U, Grover R, Videkar C, et al. Comment on: the role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degeneration. Indian J Ophthalmol. 2019;67(10):1783. doi:10.4103/ijo.IJO_160_19
   PubMed Web of Science ®Google Scholar
• Munk M, Arendt P, Yu S, et al. The impact of the vitreomacular interface in neovascular age-related macular degeneration in a treat-and- extend regimen with exit strategy. Ophthalmol Retina. 2018;2:288–294. doi:10.1016/j.oret.2017.07.010
   PubMedGoogle Scholar